InvestorsHub Logo
Followers 10
Posts 641
Boards Moderated 0
Alias Born 06/18/2007

Re: G8TSTFL post# 42651

Friday, 10/28/2022 3:16:53 PM

Friday, October 28, 2022 3:16:53 PM

Post# of 43784
Your $12B expectation is ridiculous & unrealistic. The wide use window for Multikine isn't long enough. Cutting edge understanding of cancer cellular dynamics are currently finding expression in clinical trials. In addition, it will take time to erode Keytruda's market share (after additional small scale alternative use clinical trials for Multikine). I expect an accepted buyout offer to ranger from 3-6B.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News